BEDMINSTER NJ AND DUBLIN IRELANDMarketwired November 09 2015 Amarin Corporation plc NASDAQ AMRN today commented on new data from the CHERRY study that supports the hypothesis under investigation in Amarin's cardiovascular outcomes study of Vascepa icosa...
↧